Germany Biological Sample Handling Market 2022-2028

Germany Biological Sample Handling Market 2022-2028

Germany biological sample handling market is at a growing phase, projecting a CAGR of 7.7% during the forecast period (2021-2028). As per OMR analysis, Germany biological sample handling market was valued at $41.4 million in 2021, which is estimated to reach $73.0 million in 2028, by projecting a CAGR of 7.7% during the forecast period (post-COVID-19 scenario). In 2021, Germany biological sample handling market is expected to foresee a growth of 12.9%, nearly $2.5 million due to the outbreak of the COVID-19 pandemic in Germany. During the COVID-19 pandemic, the demand for biological sample handling increased for the storage and preparation of COVID-19 samples. Therefore, the COVID-19 pandemic has upsurged the demand for biological sample handling in Germany.

Germany biological sample handling market is at a growing phase, projecting a CAGR of 7.7% during the forecast period (2021-2028). As per OMR analysis, Germany biological sample handling market was valued at $41.4 million in 2021, which is estimated to reach $73.0 million in 2028, by projecting a CAGR of 7.7% during the forecast period (post-COVID-19 scenario). In 2021, Germany biological sample handling market is expected to foresee a growth of 12.9%, nearly $2.5 million due to the outbreak of the COVID-19 pandemic in Germany. During the COVID-19 pandemic, the demand for biological sample handling increased for the storage and preparation of COVID-19 samples. Therefore, the COVID-19 pandemic has upsurged the demand for biological sample handling in Germany.

Segmentation Outlook

For estimating the market value, the biological sample handling market is broadly classified based on storage type, application, and ownership.

Based on the storage type, the market is segmented into cold storage and room temperature storage. Cold storage segment is estimated to dominate the market with 77.0% of share in 2021. Germany cold storage of biological sample handling generated $31.9 million in 2021, which is further estimated to reach $57.2 million in 2028, exhibiting a CAGR of 8.0% during the forecast period. In Germany, the cold storage biological sample handling instruments are extensively used, owing to their increasing application in proteomics and genomics R&D and drug discovery. Biological samples often degrade over time, which give rise to the demand for its storage and preservation. A huge number of biological samples collected by research institutes, hospitals, and other healthcare organizations are often stored in cold environments to preserve them for future use. Moreover, the demand for cold storage biological sample handling increased post the outbreak of COVID-19 pandemic, in applications of storing the COVID-19 samples in cold temperature, as per the guidelines of WHO.

Based on application, the market is segmented into drug discovery, forensic investigation, DNA extraction, proteomics and genomics studies, and others. In Germany, the drug discovery segment is estimated to dominate the biological sample handling market with 45.5% of the share, contributing $18.8 million in the total market value in 2021. This value is further estimated to reach $33.5 million in 2028, growing at a CAGR of 7.8% during the forecast period. The emerging bioanalysis has been accepted as a critical tool in the process of drug discovery and development in the country. During drug discovery and development, thousands of biological samples are compared that include sample from patients as well as healthy individuals. This is increasing the demand for biological sample handling in the drug discovery and development procedure in Germany, and hence, contributes to the segmental growth of the market in the country.

Moreover, the applications for biological sample handling in proteomics and genomics is expected to increase in Germany. As per OMR analysis, the proteomics and genomics is the fastest growing application, at a CAGR of 8.6%, in Germany biological sample handling market during the forecast period. The market was valued at $10.2 million in 2021, which is expected to reach $19.0 million in 2028. The rising focus of government on genome research through funding for genomic and proteomic research programs in the country is expected to propel the market growth during the forecast period. For instance, DFG, German Research Foundation established the Priority Programme “Spatial Genome Architecture in Development and Disease” in May 2021. The programme is designed to run for six years and will receive funding for the first-three years. The goal of this programme is to dissect the structure-to-function relationship of the genomes of higher metazoans at high spatio-temporal resolution in study systems relevant to genome integrity, development, or disease.

Based on application, the market is segmented into drug discovery, forensic investigation, DNA extraction, proteomics and genomics studies, and others. In Germany, the drug discovery segment is estimated to dominate the biological sample handling market with 45.5% of the share, contributing $18.8 million in the total market value in 2021. This value is further estimated to reach $33.5 million in 2028, growing at a CAGR of 7.8% during the forecast period. The emerging bioanalysis has been accepted as a critical tool in the process of drug discovery and development in the country. During drug discovery and development, thousands of biological samples are compared that include sample from patients as well as healthy individuals. This is increasing the demand for biological sample handling in the drug discovery and development procedure in Germany, and hence, contributes to the segmental growth of the market in the country.

Moreover, the applications for biological sample handling in proteomics and genomics is expected to increase in Germany. As per OMR analysis, the proteomics and genomics is the fastest growing application, at a CAGR of 8.6%, in Germany biological sample handling market during the forecast period. The market was valued at $10.2 million in 2021, which is expected to reach $19.0 million in 2028. The rising focus of government on genome research through funding for genomic and proteomic research programs in the country is expected to propel the market growth during the forecast period. For instance, DFG, German Research Foundation established the Priority Programme “Spatial Genome Architecture in Development and Disease” in May 2021. The programme is designed to run for six years and will receive funding for the first-three years. The goal of this programme is to dissect the structure-to-function relationship of the genomes of higher metazoans at high spatio-temporal resolution in study systems relevant to genome integrity, development, or disease.